Items where Author is "Deuster , S."

2022

Taji Heravi, A. and Henn, A. and Deuster, S. and McLennan, S. and Gloy, V. and Mitter, V. R. and Briel, M. and Making Randomized Trials Affordable Group, . (2022) Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: a mixed-methods study. PLoS One, 17 (3). e0264427.

2021

Speich, B. and Logullo, P. and Deuster, S. and Marian, I. R. and Moschandreas, J. and Taji Heravi, A. and Gloy, V. and Briel, M. and Hopewell, S. and Making Randomized Trials Affordable Group, . (2021) A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials. J Clin Epidemiol, 131. pp. 70-78.

2016

Hafner, P. and Bonati, U. and Erne, B. and Schmid, M. and Rubino, D. and Pohlman, U. and Peters, T. and Rutz, E. and Frank, S. and Neuhaus, C. and Deuster, S. and Gloor, M. and Bieri, O. and Fischmann, A. and Sinnreich, M. and Gueven, N. and Fischer, D.. (2016) Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study. PLoS ONE, 11 (1). e0147634.

2015

Wicki, A. and Ritschard, R. and Loesch, U. and Deuster, S. and Rochlitz, C. and Mamot, C.. (2015) Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial. International Journal of Pharmaceutics, 484 (1-2). pp. 8-15.

2012

Hardmeier, M. and Zimmermann, R. and Rüegg, S. and Pflüger, M. and Deuster, S. and Suter, K. and Donzelli, M. and Drewe, J. and Krähenbühl, S. and Fuhr, P. and Haschke, M.. (2012) Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers. Clinical Pharmacology & Therapeutics, 91 (5). pp. 856-862.

Mamot, C. and Ritschard, R. and Wicki, A. and Stehle, G. and Dieterle, T. and Bubendorf, L. and Hilker, C. and Deuster, S. and Herrmann, R. and Rochlitz, C.. (2012) Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study. The Lancet oncology, Vol. 13, H. 12. pp. 1234-1241.

2010

Deuster, S. and Roten, I. and Muehlebach, S.. (2010) Implementation of treatment guidelines to support judicious use of antibiotic therapy. Journal of clinical pharmacy and therapeutics, Vol. 35, H. 1. pp. 71-78.

2009

Deuster, S. and Roten, I. and Mühlebach, S.. (2009) Intervention study about implementation and follow-up of treatment guidelines to improve rational antibiotic therapy in a teaching hospital. Journal of clinical pharmacy and therapeutics, Vol. 34. pp. 1-8.

2005

Mühlebach , Stefan F. and Deuster , S.. (2005) Chemisch-physikalische Inkompatibilitäten parenterale verabreichter Arzneimittel (Zumischen von Arzneimitteln zu Infusionslösungen). In: Grundlagen der Arzneimitteltherapie. Basel, pp. 234-239.